Alexium International Group Ltd (ASX: AJX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Alexium International Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $22.28 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 3.18 billion
Earnings per share -0.003
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Alexium International Group Ltd (ASX: AJX)
    Latest News

    man grimaces next to falling stock graph
    ⏸️ ASX Shares

    What's going on with the Alexium (ASX:AJX) share price?

    The specialty chemicals group has today given an insight into its trading halt

    Read more »

    Child with superhero mask and cape flies after jumping on sofa
    Share Gainers

    Alexium (ASX:AJX) share price rockets 34% on sales update

    Shares in the textiles producer have been surging but are currently in a pause in trading...

    Read more »

    child in superman outfit pointing skyward, indicating a rising share price
    ASX Share Market News

    Here's why the Alexium (ASX:AJX) share price surged 9% today

    The advanced materials company has big things in store in FY22.

    Read more »

    a woman
    Share Gainers

    Why the Alexium share price is up 25% this week

    The Alexium share price has soared higher following the announcement of an exclusive development agreement.

    Read more »

    a woman
    Share Gainers

    These small cap ASX shares have started the week on a high

    The Food Revolution Group Ltd (ASX:FOD) share price is one of three at the small end of the market starting…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares started the week in the red

    The Retail Food Group Limited (ASX:RFG) share price is one of four starting the week in the red. Here’s why…

    Read more »

    a woman
    ⏸️ Investing

    Why shares of Alexium International Group Ltd are down today

    Shares in chemical development company Alexium International Group Ltd (ASX:AJX) are down 5.26% in morning trade to 36 cents following an…

    Read more »

    a woman
    ⏸️ Investing

    One investment idea for FY18 that you've probably missed

    Wondering what stock investment ideas will pay off in the new financial year? Defence technology is one area you cannot…

    Read more »

    a woman
    ⏸️ Investing

    The Alexium International Group Ltd share price is up 21% this week

    The Alexium International Group Ltd (ASX:AJX) share price has been a big mover once again. Here’s what you need to…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares have posted solid gains today

    The St Barbara Ltd (ASX:SBM) share price is one of four climbing notably higher today. Here’s what you need to…

    Read more »

    a woman
    ⏸️ Investing

    Alexium International Group Ltd: A promising small-cap?

    Should you buy Alexium International Group Ltd (ASX:AJX) shares today?

    Read more »

    a woman
    ⏸️ Investing

    Why these 5 ASX shares have rocketed higher today

    Bubs Australia Ltd (ASX:BUB) has been one of the standouts on the ASX today with a massive gain. Here’s why…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    26 Mar 2004 $0.0200 100.00% Interim 15 Apr 2004

    AJX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Alexium International Group Ltd

    Alexium International Group Ltd. engages in the provision of developing chemical solutions. It is involved in the development and licensing of its proprietary flame retardant phase change material, chemicals and reactive surface treatment technologies. Its products include Alexicool, Alexiflam FR and Alexiflam NF. The company was founded on May 30, 1994 and is headquartered in Greer, SC.

    AJX Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    19 Nov 2026 $0.01 $0.00 0.00% 1,185,853 $0.01 $0.01 $0.01
    11 Nov 2026 $0.01 $0.00 0.00% 597,821 $0.01 $0.01 $0.01
    10 Nov 2026 $0.00 $0.00 0.00% 60,000 $0.00 $0.00 $0.00
    29 Oct 2026 $0.01 $0.00 0.00% 16,715 $0.01 $0.01 $0.01
    27 Oct 2026 $0.01 $0.00 0.00% 6,050 $0.01 $0.01 $0.01
    26 Oct 2026 $0.01 $0.00 0.00% 23,589 $0.01 $0.01 $0.01
    23 Oct 2026 $0.01 $0.00 0.00% 50,000 $0.01 $0.01 $0.01

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    02 Nov 2026 William (Billy) Blackburn Issued 8,338,857 $50,033
    Issue of securities. Estimated value per share: $0.006
    09 Oct 2026 William (Billy) Blackburn Expiry 6,712,233 $40,273
    As advised by the company. 6,712,233 rights lapsed; 92,354,851 Share Appreciation Rights
    22 Sep 2026 Simon Moore Issued 12,330,616 $81,382
    Director remuneration. as per announcement 25-09-26
    22 Sep 2026 James Williamson Issued 6,165,315 $40,691
    Director remuneration.
    22 Sep 2026 Paul Stenson Issued 4,007,454 $26,449
    Director remuneration.
    22 Sep 2026 Martyn Strickland Issued 6,165,315 $40,691
    Director remuneration. As per announcement 25-09-26
    22 Sep 2026 T Lane Issued 11,172,480 $73,738
    Director remuneration.
    28 Jan 2026 Martyn Strickland Issued 809,044,333 $4,854,265
    Rights issue.
    28 Jan 2026 Simon Moore Issued 809,044,333 $4,854,265
    Rights issue.
    28 Jan 2026 William (Billy) Blackburn Issued 16,659,830 $99,958
    Rights issue.
    28 Jan 2026 Paul Stenson Issued 6,195,833 $37,174
    Rights issue.
    28 Jan 2026 T Lane Issued 10,127,605 $60,765
    Rights issue.
    28 Jan 2026 James Williamson Issued 136,981,856 $821,891
    Rights issue.
    17 Dec 2025 Simon Moore Issued 9,715,591 $68,009
    Director remuneration. As per announcement on 17-12-2025
    17 Dec 2025 Martyn Strickland Issued 4,857,803 $34,004
    Director remuneration. As per announcement 17/12/2025
    17 Dec 2025 James Williamson Issued 8,373,970 $58,617
    Director remuneration.
    17 Dec 2025 Paul Stenson Issued 3,157,570 $22,102
    Director remuneration.
    17 Dec 2025 T Lane Issued 3,157,570 $22,102
    Director remuneration.
    12 Dec 2025 William (Billy) Blackburn Issued 66,491,935 $465,443
    Issue of securities. 99,067,084 rights
    12 Dec 2025 T Lane Issued 8,063,233 $56,442
    Issue of securities. 8,063,233 Share Appreciation Rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Simon Colinton Moore Non-Executive DirectorInterim Chairman Feb 2020
    Mr Moore is the Senior Partner of the investment firm, Colinton Capital Partners. Prior to establishing Colinton Capital Partners in 2017, Mr Moore was a Global Partner of The Carlyle Group having established their operation in Australia in 2005. In his time at The Carlyle Group, he oversaw the Firm's investments in and served on the Boards of Directors of Coates Hire, Healthscope and QUBE. He is currently a member of the Risk Committee.
    Dr Paul Henry Stenson Non-Executive Director Jun 2020
    Dr Stenson has a career with the research, development, manufacture, and commercialization of new materials in the fields of coatings, adhesives, nonwovens, and pharmaceuticals. Dr Stenson was President and CEO of StanChem Inc. from January 2018 to April 2024. StanChem Inc. is comprised of two companies - StanChem Polymers which is a manufacturer of water-based polymers for the coatings and adhesives industries, and Albi Protective Coatings which focuses on the specialty sector of fire protective intumescent paints and specialty high-performance industrial coatings. Prior to joining StanChem in 2017, he worked as a global technology director at Axalta Coating Systems. Between 2011 and 2016, Dr Stenson was the executive vice president of technology and product development at Ahlstrom for nonwoven and specialty high-performance paper products. Prior to joining Ahlstrom, Dr Stenson was the vice president of technology for industrial and packaging coatings at Valspar based in Minneapolis and Zurich, Switzerland from 1993 until 2011. Dr Stenson is also the chairman of TopChem Pharmaceuticals (Ireland) which is a manufacturer of active pharmaceutical ingredients. He is the chair of the Risk Committee.
    Mr William (Billy) Timothy Blackburn Chief Executive OfficerManaging Director Sep 2022
    Mr Blackburn has over 25 years of experience in general management. He founded Emes, LLC, a technology-based specialty chemical business. Emes had a business model focused on high-purity chemical production paired with recycling in the pharmaceutical and consumer healthcare markets. Mr. Blackburn sold the business to Nova Molecular and then joined their executive team to lead further commercial growth of the merged organizations. More recently, Mr. Blackburn was the Vice President of Giant Cement Holdings Inc., and executive manager of its subsidiary, Giant Resource Recovery (GRR). He also raised capital for the GRR business to modernize its plants for sustained growth.
    Mr T Randall Lane Non-Executive Director Jul 2024
    Mr Lane has had a career in research, manufacturing, start-ups and product commercialization including 25 years of senior management positions in the chemical and medical device industries. Specifically, he has served as CEO/CSO at CAVU group, comprised of Microtek, American Thermal Instruments and Latent Heat Solutions. Mr. Lane has also served on several Boards in the private sector.
    Mr Martyn Strickland Non-Executive Director Jul 2024
    Mr Strickland prior to joining Colinton Capital Partners, was a Senior Partner at Deloitte, where he led their middle-market strategy and the Operational Restructuring and CRO services divisions within the Financial Advisory business. Prior to Deloitte, Martyn joined KordaMentha as Managing Director to establish their 333 Consulting business focusing on company side turnaround, restructuring and growth. Prior to 333, Martyn was Principal with A.T. Kearney and an Operating Executive with Cadbury Schweppes. Mr Strickland is a member of the Risk Committee.
    Mr James Williamson Interim Non-Executive Director Nov 2024
    Mr Williamson has over 30 years of experience in financial markets and is the Co-Founder and Chief Investment Officer of Wentworth Williamson Management. Founded in 2013, Wentworth Williamson Management is a private Australian-based value fund manager with both equity and private credit funds. Prior to Wentworth Williamson, Mr Williamson worked for Allan Gray Australia and prior to that he was Portfolio Manager of the Investec Australian Equity Fund.
    Ms Sandra McIntosh Company Secretary Mar 2026
    -
    Sandra McIntosh Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Colinton Capital Partners Pty Ltd <Colinton Cp Fund 1 (A) A/C> 1,061,013,112 33.92%
    Colinton Capital Partners Pty Ltd 580,289,944 18.55%
    Microtek Holdings Inc 361,717,485 11.56%
    Sandhurst Trustees Ltd <Wentworth Williamson A/C> 306,984,033 9.81%
    Dr Stuart Lloyd Phillips & Mrs Fiona Jane Phillips <Sl & Fj Phillips Pens F A/C> 186,576,008 5.97%
    N & G Td Proprietary Limited <N & G Td Super Fund A/C> 46,000,000 1.47%
    Dr Elyse Jane Phillips 39,999,999 1.28%
    Dr Paul Stenson 30,331,404 0.97%
    William T Blackburn Jr 28,659,830 0.92%
    Randall Lane 21,184,918 0.68%
    Mr Michael Joseph Duhamel & Ms Kathleen Mary Beaman <Duhamel & Beaman S/F A/C> 21,000,000 0.67%
    Bnp Paribas Nominees Pty Ltd <Clearstream> 18,821,779 0.60%
    Mrs Sandra Kaye Conti 12,920,000 0.41%
    Mr Joseph John Hill 12,000,000 0.38%
    Rosheen Garnon 11,483,822 0.37%
    HSBC Custody Nominees (Australia) Limited <Gsco Customers A/C> 10,032,000 0.32%
    Ducky'S Lifeline Pty Ltd <The R Edwards Super A/C> 8,826,670 0.28%
    Aubergiste Pty Ltd <Mfc Discretionary A/C> 8,512,229 0.27%
    Wentworth Williamson Management Pty Ltd 8,373,970 0.27%
    Mr Mark Shane Aitken 8,140,000 0.26%

    Profile

    since

    Note